Trial Details
TERMINATEDBasic Information
| Clinical ID | c1484 |
|---|---|
| Identifier | NCT04978493 |
| Trial Title | A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: BI 706321|DRUG: Ustekinumab|DRUG: Placebo |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Northridge |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-12-02 |
|---|---|
| Primary Completion Date | 2024-07-08 |
| Completion Date | 2024-08-08 |